Drugs / Danshu
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04484870 | Mar 2017 → Jul 2018 | choledocholithiasis | First People's Hospital of Hangzhou | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Danshu | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04484870 ↗ |
| Route | Oral | “Danshu group oral Danshu capsule” NCT04484870 ↗ |